[go: up one dir, main page]

MX9700813A - Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos. - Google Patents

Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.

Info

Publication number
MX9700813A
MX9700813A MX9700813A MX9700813A MX9700813A MX 9700813 A MX9700813 A MX 9700813A MX 9700813 A MX9700813 A MX 9700813A MX 9700813 A MX9700813 A MX 9700813A MX 9700813 A MX9700813 A MX 9700813A
Authority
MX
Mexico
Prior art keywords
medicaments
substituted
preparation
new
benzodiazepine derivatives
Prior art date
Application number
MX9700813A
Other languages
English (en)
Inventor
Tam S H Mori
Istv N Tarnawa
S Ndor Salyom
P L Berzsenyi
Erzsebet Birk S Falglne
Ferenc Andr Si
Istv N Ling
Tibor Haska
G Bor Kapus
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of MX9700813A publication Critical patent/MX9700813A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

Se describen derivados 3-substituido de 3H-2,3-benzodiazepina de la formula general I (Ver Formula) en la cual R1, R2, R3, R4, R5, R6, R7 y n tienen los significados dados en la descripcion, su preparacion así como su uso como medicamento.
MX9700813A 1994-08-01 1995-07-28 Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos. MX9700813A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4428835A DE4428835A1 (de) 1994-08-01 1994-08-01 Neue 3-substituierte 3H-2,3-Benzodiazepinderivate, deren Herstellung und Verwendung als Arzneimittel
PCT/DE1995/001029 WO1996004283A1 (de) 1994-08-01 1995-07-28 Neue 3-substituierte 3h-2,3-benzodiazepinderivate, deren herstellung und verwendung als arzneimittel

Publications (1)

Publication Number Publication Date
MX9700813A true MX9700813A (es) 1997-05-31

Family

ID=6525693

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9700813A MX9700813A (es) 1994-08-01 1995-07-28 Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.

Country Status (21)

Country Link
US (1) US5756495A (es)
EP (1) EP0775143B1 (es)
JP (1) JPH10504543A (es)
KR (1) KR100386709B1 (es)
CN (1) CN1048728C (es)
AT (1) ATE223415T1 (es)
AU (1) AU693241B2 (es)
CA (1) CA2195747C (es)
CZ (1) CZ291276B6 (es)
DE (2) DE4428835A1 (es)
DK (1) DK0775143T3 (es)
ES (1) ES2181787T3 (es)
FI (1) FI113177B (es)
HU (1) HU225500B1 (es)
MX (1) MX9700813A (es)
NO (1) NO319151B1 (es)
NZ (1) NZ290777A (es)
PT (1) PT775143E (es)
RU (1) RU2146678C1 (es)
SK (1) SK284103B6 (es)
WO (1) WO1996004283A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9701325A1 (hu) 1997-07-31 2000-08-28 Gyógyszerkutató Intézet Kft. Új 2,3-benzodiazepin-származékok
CN1271360A (zh) * 1997-08-12 2000-10-25 埃吉斯药物工厂 作为ampa/红藻氨酸受体抑制剂的1,3－二氧杂环戊烷并/4,5－h//2,3/苯并－二氮杂䓬衍生物
UA67749C2 (uk) * 1997-08-12 2004-07-15 Егіш Дьйодьсердьяр Рт. Похідна 8-заміщеного-9н-1,3-діоксол/4,5-h//2,3/бензодіазепіну з властивостями амра/каїнатного антагоніста, спосіб одержання похідних, фармацевтична композиція (варіанти), спосіб її одержання та спосіб лікування
HU227128B1 (en) * 1999-07-07 2010-07-28 Egyt Gyogyszervegyeszeti Gyar New 2,3-benzodiazepine derivatives
NO320473B1 (no) * 2002-09-09 2005-12-12 Norsk Hydro As Anordning ved separator for separasjon av flerfasefluid.
US6858605B2 (en) 2003-02-04 2005-02-22 Ivax Drug Research Institute, Ltd. Substituted 2,3-benzodiazepine derivatives
GB0405034D0 (en) * 2004-03-05 2004-04-07 Novartis Ag Organic compounds
WO2006107860A2 (en) * 2005-04-04 2006-10-12 Eisai Co., Ltd. Dihydropyridine compounds and compositions for headaches
MX2008003170A (es) * 2005-09-09 2008-03-18 Novartis Ag Tratamiento de enfermedades autoinmunes.
WO2015121268A1 (de) * 2014-02-14 2015-08-20 Bayer Pharma Aktiengesellschaft 1-phenyl-3h-2,3-benzodiazepine und ihre verwendung als bromodomänen-inhibitoren

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU219778B (hu) * 1990-12-21 2001-07-30 Gyógyszerkutató Intézet Közös Vállalat Eljárás N-acil-2,3-benzodiazepin-származékok, savaddíciós sóik és az ezeket tartalmazó gyógyászati készítmények előállítására, valamint a vegyületek egy csoportja, és az ezeket tartalmazó gyógyászati készítmények
SI9111433B (sl) * 1991-08-22 1999-02-28 Pliva Novi N-sulfonil-tetrahidro-/1,3/-dioksepino/5,6-b/azirini, postopek priprave, intermediati za njihovo pripravo in uporaba

Also Published As

Publication number Publication date
HU225500B1 (en) 2007-01-29
EP0775143B1 (de) 2002-09-04
KR100386709B1 (ko) 2003-08-19
NO970435D0 (no) 1997-01-31
SK284103B6 (sk) 2004-09-08
DE4428835A1 (de) 1996-02-08
CA2195747A1 (en) 1996-02-15
JPH10504543A (ja) 1998-05-06
FI113177B (fi) 2004-03-15
NO970435L (no) 1997-01-31
HUT76801A (en) 1997-11-28
EP0775143A1 (de) 1997-05-28
CZ15997A3 (en) 1997-06-11
CZ291276B6 (cs) 2003-01-15
FI970434A0 (fi) 1997-01-31
RU2146678C1 (ru) 2000-03-20
WO1996004283A1 (de) 1996-02-15
SK13597A3 (en) 1997-07-09
CN1048728C (zh) 2000-01-26
ATE223415T1 (de) 2002-09-15
ES2181787T3 (es) 2003-03-01
DK0775143T3 (da) 2002-12-02
DE59510364D1 (de) 2002-10-10
CA2195747C (en) 2006-01-24
AU693241B2 (en) 1998-06-25
NZ290777A (en) 1998-07-28
NO319151B1 (no) 2005-06-27
CN1155285A (zh) 1997-07-23
FI970434L (fi) 1997-01-31
PT775143E (pt) 2003-01-31
AU3160995A (en) 1996-03-04
US5756495A (en) 1998-05-26

Similar Documents

Publication Publication Date Title
NO931635L (no) Fremgangsmaate for fremstilling av kinazolin-derivater
BG103251A (bg) Оксадиазоли, методи за получаването им и приложението им като лекарствени средства
MY118498A (en) Lactam derivatives
NZ233735A (en) Heterocyclic substituted aminophenol derivatives
MX9805181A (es) Derivados de lactona a partir de derivados de 17.beta- carboxi, carbotio y amida androstano.
GEP20002331B (en) Alkylated Raphamicine Derivatives
WO1996032003A3 (en) Tetrahydroimidazopyridoindolediones and their use as medicaments
CA2160447A1 (en) Amino(thio)ether derivatives
NZ239514A (en) Oxazole-substituted hydroxy-urea and cyclised hydroxy-urea derivatives, intermediate compounds and medicaments
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
BG102616A (en) Substituted aza- and diazacycloheptane and cyclooctane derivatives and their application
MX9709240A (es) Fenilpiridazinonas.
MX9802383A (es) Derivados de pirimidina como antagonistas del receptor 5ht26.
BG103399A (en) New heterocycle-substituted benzamides and their application for the treatment of diseases
IL133824A0 (en) Tetrazole derivatives, medicaments containing same and use thereof
ES2184077T3 (es) Nuevas fenantridinas sustituidas en la posicion 6.
IT1285770B1 (it) Composti corticoidei
MY101520A (en) Indoline and 2-indolinone derivatives.
RU95101375A (ru) Производные n-(3-аминопропил)-n-фенил-5,6,7,8-тетрагидронафталин-2-карбоксамида, их получение и применение в терапии
IL140070A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
TR200001102T2 (tr) İkameli tetrahidropirimidinen türevleri, üretimleri ve kullanımları.
MX9700813A (es) Nuevos derivados 3-substituidos de 3h-2,3-benzodiazepina, su preparacion y su uso como medicamentos.
MY132057A (en) Quinoxalinones, a process for their preparation and their use
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
GR3036907T3 (en) Dihygropyridine derivatives as bradykinin antagonists